COSM Overview

Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.

Wall Street analysts forecast COSM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for COSM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Cosmos Health Inc revenue for the last quarter amounts to 17.93M USD, increased 30.74

Cosmos Health Inc. EPS for the last quarter amounts to -0.06 USD, increased 100.00

Cosmos Health Inc (COSM) has 163 emplpoyees as of June 20 2026.

Today COSM has the market capitalization of 15.00M USD.